SynthesisAlimentary pharmacology & therapeutics2025
Systematic Review: Ultrasound Goes Echo-Decarbonising Inflammatory Bowel Disease Care Through Intestinal Ultrasound.
Synthesis in Alimentary pharmacology & therapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Intestinal ultrasound in primary intestinal lymphangiectasia (Waldmann's disease): a PRISMA-ScR scoping review with an illustrative adult case.Journal of ultrasound · 2026Review
- The Emerging Role of Ultrasonography in Ulcerative Colitis.Diagnostics (Basel, Switzerland) · 2026Review
- Integrating Intestinal Ultrasound in the Personalized Management of IBD.Journal of personalized medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInflammatory bowel disease (IBD) is a chronic, resource-intensive condition requiring repeated diagnostic assessments. Healthcare contributes ~5% of global greenhouse gas emissions, and key diagnostic tools in IBD-gastrointestinal (GI) endoscopy, computed tomography (CT) and magnetic resonance imaging (MRI)-are associated with substantial environmental impacts. The environmental burden of these diagnostic pathways, however, remains underappreciated.
aimTo systematically assess the carbon footprint and environmental impact of diagnostic imaging modalities commonly used in IBD, with particular focus on intestinal ultrasound (IUS) as a sustainable, low-carbon alternative.
methodsA systematic review was conducted according to PRISMA 2020 guidelines. PubMed, Scopus and Embase were searched from inception to May 2025 for studies reporting the environmental impact of diagnostic modalities relevant to IBD care (GI endoscopy, CT, MRI and IUS). Studies providing quantitative or qualitative data on carbon footprint, energy consumption, waste generation or sustainability metrics were included. Data were synthesised narratively.
resultsThirty-one studies were included. GI endoscopy generates approximately 7.8-56.4 kg CO
conclusionGI endoscopy, CT and MRI are indispensable in IBD care but carry considerable environmental costs. The broader adoption of IUS offers a clinically effective, low-carbon alternative that can contribute to more sustainable IBD management, aligning with planetary health goals.
trial registrationPROSPERO International Prospective Register of Systematic Reviews: CRD420251088016.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.